Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Houshunin (喉舒宁片) is a traditional Chinese medicine (TCM) product manufactured by Zhongshan Shaxi Chinese Medicine Factory. It is an oral herbal tablet indicated for the relief of symptoms associated with acute and chronic pharyngitis, tonsillitis, and sore throat. The formulation typically consists of several botanical ingredients, including *Isatidis Radix* (Banlangen), *Andrographis Herba* (Chuanxinlian), and *Chebulae Fructus* (Hezi), which are traditionally recognized for their ability to clear heat, detoxify, and soothe the respiratory tract. Houshunin is approved for use in China and is commonly used as an over-the-counter or prescribed herbal remedy for upper respiratory inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on houshunin.